ALTSTATION.IO

Equifax Inc. (EFX) Stock Analysis

By Nova Skye | AltStation.io | Updated February 07, 2026

Price
$194.90
Change
+2.03%
Market Cap
$23.85B
Avg Volume
1.7M

Company Overview

Equifax Inc. is a data, analytics, and technology company headquartered in Atlanta, Georgia. They provide a range of services across three main segments: Workforce Solutions, U.S. Information Solutions, and International. Their offerings include credit information, employment verification, fraud detection, identity verification, and payroll automation, targeting businesses, financial institutions, and government agencies. Essentially, Equifax helps organizations make informed decisions by providing critical data on consumers and employees.

Equifax holds a strong position in the market, often viewed as a leader in the credit reporting and information solutions sector. Their extensive data repositories and advanced analytics capabilities give them a competitive edge over smaller players. However, they face threats from regulatory scrutiny and increasing competition from companies like Experian and TransUnion, which also provide similar data services. The market is evolving, with a growing emphasis on data privacy and security, which could impact their operational dynamics.

Currently, Equifax is in a growth phase, focusing on digital transformation and enhancing their technology platform. They’re investing heavily in machine learning and AI to improve their analytics capabilities. Recent milestones include partnerships aimed at expanding their international reach and strengthening their product offerings. This strategy positions them well to capitalize on emerging trends in data-driven decision-making and identity verification.

Key Financials
Market Cap
$23.85B
Revenue
$6.07B
EBITDA
$1.82B
Gross Margin
56.4%
Profit Margin
10.9%
Revenue Growth
9.2%
Total Cash
$180.80M
Total Debt
$5.09B
Free Cash Flow
$966.81M


52-Week Price Performance Analysis

Price Statistics
P/E Ratio
36.57
Forward P/E
18.66
Beta
N/A
52-Week High
$281.03
52-Week Low
$166.02
EPS
$5.33
50-Day Avg
$212.76
200-Day Avg
$238.91
Price/Book
5.10
EFX 52-Week Stock Chart
Technical Analysis
Over the past 52 weeks, Equifax Inc. (EFX) has shown a pronounced downtrend, with the stock currently priced at $194.90, reflecting a significant decline of 22.0% from its previous levels. Key resistance is identified at the $240 level, which has consistently capped upward movements, while support appears strong near $180, indicating a potential floor for the stock’s value. A notable price pattern is the formation of lower highs and lower lows throughout the year, confirming bearish momentum. Recent weeks illustrate a slight rebound in price but remain under the long-term downtrend suggested by the declining resistance lines. The current price sits near the lower end of its 52-week range, significantly below its peak around $280, which implies continued bearish sentiment and highlights potential volatility as traders assess the stock’s future direction.


Recent News and Developments

Here are the latest news and developments for Equifax Inc

(EFX) stock in the past week:

Market Update

### Equifax Reports Strong Q4 2025 Earnings and Issues Optimistic 2026 Guidance

Market Update

Equifax (NYSE: EFX) announced strong financial results for the fourth quarter and full year ended December 31, 2025, on February 4, 2026. The credit services provider reported $2.09 earnings per share (EPS) for the quarter, surpassing the consensus estimate of $2.05 by $0.04. Revenue for the quarter reached $1.551 billion, a 9% increase year-over-year, and exceeded analysts’ expectations of $1.53

Market Sentiment and Analyst Recommendations

Bull Case
Equifax just beat Q4 earnings by $0.04 EPS and revenue by $21 million, signaling solid execution. The 2026 guidance of $6.66-$6.78B revenue and $8.30-$8.70 EPS implies 9-10% growth, which is respectable for a $23.85B market cap company with recurring revenue. The new AI-powered fraud detection and income verification products address real pain points for lenders and auto finance firms, creating near-term upsell opportunities. At 36.57 P/E, the stock is trading below its historical average and well below the $244.50 analyst target, leaving 25% upside if the market reprices on execution. Twenty analysts recommend a buy, and the company has $180.8M in cash against $5.09B debt, which is manageable for a profitable, cash-generative business. The stock is near $180 support after a 22% decline from peak, which has historically attracted institutional buyers in this name.
Bear Case
The 22% decline from the $281 peak reflects real structural concerns that one earnings beat doesn’t erase. Regulatory scrutiny over Medicaid profiteering is a legitimate threat to future revenue streams and margins, especially if politicians push for price controls or contract restrictions. The stock has formed lower highs and lower lows over the past 52 weeks, confirming a downtrend that hasn’t reversed despite the earnings beat. A P/E of 36.57 is still expensive for a company growing at 9.2%, and some analysts already trimmed price targets after Q4, signaling consensus weakness. The $240 resistance level has consistently capped rallies, suggesting institutional sellers are waiting to exit. Equifax operates in a politically sensitive space where consumer data protection and fairness are becoming flashpoints, and one regulatory misstep could tank the stock harder.
What to Watch
Monitor 2026 revenue growth execution against the $6.66-$6.78B guidance range. Any miss or downward revision would confirm the bearish chart pattern and likely break support at $180. Track adoption rates and revenue contribution from the new AI fraud detection and income verification products, which should show up in quarterly earnings starting Q1 2026. Watch for regulatory developments on Medicaid, specifically any legislative proposals or Senate hearings that could restrict Equifax’s pricing or contract scope. The $240 resistance level is critical. A sustained break above it would signal institutional accumulation and validate the bull case. Conversely, a drop below $180 would suggest the downtrend has room to run. Pay attention to management commentary on margin expansion, since the 2026 guidance implies flat or slightly declining margins if revenue grows at the low end of guidance.
Analyst Consensus
BUY

Based on 20 analyst opinions
Low Target
$195.00
Mean Target
$244.50
High Target
$283.00


Earnings and Financial Data

Sector
Industrials
Industry
Consulting Services
Employees
15,000


Earnings & Dividends
Next Earnings
Apr 21, 2026
EPS (Trailing)
$5.33
Dividend Yield
105.0%
Payout Ratio
35.5%

Frequently Asked Questions

Is EFX a good stock to buy?
Analysts rate Equifax (EFX) as a “BUY” with a target price of $244.50, indicating an upside of about 25% from the current price of $194.90. The forward P/E of 18.66 suggests it may be undervalued compared to its earnings growth potential.
What is EFX’s price target?
The analyst consensus target for Equifax is $244.50. This is based on growth prospects and current earnings, signaling confidence in the company’s future performance.
Does EFX pay a dividend?
Yes, Equifax has a remarkably high dividend yield of 105.0%. This yield indicates strong cash flow and a commitment to returning value to shareholders, making it attractive for income-focused investors.
What is EFX’s current market capitalization?
Equifax’s market cap stands at $23.85 billion. This size positions it as a significant player in the consulting services industry within the industrial sector.
What has been EFX’s stock price range over the past year?
Equifax’s stock has traded between $166.02 and $281.03 over the last 52 weeks. This volatility highlights both risk and opportunity, depending on market conditions and company performance.

Related Stock Reports

Disclaimer: This report is for informational purposes only and does not constitute financial advice. The analysis and opinions expressed are those of AltStation.io and should not be relied upon as the sole basis for investment decisions. Always conduct your own research and consult with a qualified financial advisor before making investment decisions. Past performance does not guarantee future results. Updated February 07, 2026.